| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 | ADUS Addus Homecare Corp | Bickham W Bradley61 | President And COO | Sell | 481 | $70.58 | $33,948.98 | -1.0% | +0.7% | +23.3% | |
| Feb 25, 2022 | ADUS Addus Homecare Corp | Poff Brian63 | Evp/ Chief Financial Officer | Sell | 692 | $70.58 | $48,841.36 | -1.9% | +0.7% | +23.3% | |
| Feb 25, 2022 | ADUS Addus Homecare Corp | Allison R Dirk65 | CEO And Chairman | Sell | 1,911 | $70.57 | $134,859.27 | -2.2% | +0.7% | +23.3% | |
| Feb 25, 2022 | ADUS Addus Homecare Corp | Gaffney Sean63 | EVP / Chief Legal Officer | Sell | 433 | $70.56 | $30,552.48 | -2.7% | +0.7% | +23.3% | |
| Feb 25, 2022 | ADUS Addus Homecare Corp | Tucker David W.64 | Evp/ Chief Development Officer | Sell | 289 | $70.54 | $20,386.06 | -2.6% | +0.7% | +23.3% | |
| Feb 25, 2022 | ADUS Addus Homecare Corp | Stevenson Roberton James62 | EVP &Chief Hr Officer | Sell | 65 | $70.54 | $4,585.10 | -1.1% | +0.7% | +23.3% | |
| Feb 25, 2022 | ADUS Addus Homecare Corp | Anderson Darby57 | Evp/ Chief Strategy Officer | Sell | 377 | $70.55 | $26,597.35 | -1.0% | +0.7% | +23.3% | |
| Feb 25, 2022 | UNH Unitedhealth Group Inc | Burke Richard T | Director | Sell | 10,000 | $468.35 | $4,683,487.60 | -0.4% | +5.9% | +3.1% | |
| Feb 25, 2022 | SGRY Surgery Partners, Inc. | Doherty David T76 | Chief Financial Officer | Sell | 2,221 | $50.48 | $112,116.08 | -3.6% | -23.5% | -35.2% | |
| Feb 24, 2022 | HSIC Henry Schein Inc | Mlotek Mark E64 | EVP, Chief Strategic Officer | Sell | 24,075 | $82.99 | $1,997,936.10 | -21.6% | +1.4% | -3.8% | |
| Feb 24, 2022 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 1,669 | $126.26 | $210,727.94 | -4.3% | +9.4% | +9.7% | |
| Feb 24, 2022 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sell | 2,750 | $126.26 | $347,215.00 | -4.1% | +9.4% | +9.7% | |
| Feb 24, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 16,660 | $35.25 | $587,249.50 | -0.8% | -12.5% | -16.6% | |
| Feb 23, 2022 | MOH Molina Healthcare, Inc. | Romney Ronna60 | Director | Sell | 300 | $311.38 | $93,412.76 | -0.9% | +2.8% | -3.4% | |
| Feb 22, 2022 | PFHO Pacific Health Care Organization Inc | Kubota Tom | CEO &President | Buy | 18,000 | $0.81 | $14,530.00 | +0.1% | - | - | |
| Feb 22, 2022 | UNH Unitedhealth Group Inc | Garcia Paul R | Director | Buy | 2,146 | $464.97 | $997,817.25 | +937.1% | +6.7% | +7.1% | |
| Feb 22, 2022 | MRAI Marpai, Inc. | Eitan Yaron | Director | Buy | 10,000 | $2.05 | $20,500.00 | +1.5% | - | - | |
| Feb 22, 2022 | DHTI Dalrada Technology Group, Inc. | Bonar Brian | Chief Executive Officer | Buy | 4,124 | $0.59 | $2,420.51 | - | - | - | |
| Feb 17, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 16,660 | $39.95 | $665,520.56 | -1.1% | -9.1% | -13.2% | |
| Feb 17, 2022 | HCA Hca Healthcare, Inc. | Moore A Bruce Jr | Group President - Service Line | Sell | 30,000 | $246.87 | $7,406,187.56 | -13.5% | -17.4% | +5.9% | |
| Feb 16, 2022 | UNH Unitedhealth Group Inc | Burke Richard T | Director | Sell | 5,000 | $476.72 | $2,383,587.50 | -0.4% | +2.9% | +2.8% | |
| Feb 16, 2022 | LH Labcorp Holdings Inc. | Neupert Peter M | Director | Buy | 3,500 | $263.66 | $922,815.00 | +14.3% | -8.1% | -4.2% | |
| Feb 16, 2022 | HSIC Henry Schein Inc | Bergman Stanley M61 | Chairman, CEO | Sell | 30,000 | $83.05 | $2,491,427.70 | -1.8% | +2.6% | -1.7% | |
| Feb 16, 2022 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 20,069 | $41.34 | $829,705.91 | -5.5% | -7.4% | -18.2% | |
| Feb 16, 2022 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 9,224 | $41.30 | $380,928.64 | -5.2% | -7.4% | -18.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.